Page last updated: 2024-08-22

aluminum sulfate and Drug Abuse, Intravenous

aluminum sulfate has been researched along with Drug Abuse, Intravenous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berman, PW; Chernow, M; Francis, DP; Heyward, WL; Hirunras, K; Kaewkangwal, J; Kitayaporn, D; Li, E; Migasena, S; Peterson, ML; Phonrat, B; Pitisuttithum, P; Raktham, S; Sheppard, HW; Shibata, R; Srisuwanvilai, LO; Suntharasamai, P	1

Trials

1 trial(s) available for aluminum sulfate and Drug Abuse, Intravenous

Article	Year
Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1. Journal of acquired immune deficiency syndromes (1999), 2004, Sep-01, Volume: 37, Issue:1 Topics: Adjuvants, Immunologic; Adolescent; Adult; AIDS Vaccines; Alum Compounds; Female; HIV Antibodies; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Immunization Schedule; Male; Middle Aged; Recombinant Proteins; Substance Abuse, Intravenous; Thailand; Vaccination	2004

Article

Year

Phase I/II study of a candidate vaccine designed against the B and E subtypes of HIV-1.

Journal of acquired immune deficiency syndromes (1999), 2004, Sep-01, Volume: 37, Issue:1

Topics: Adjuvants, Immunologic; Adolescent; Adult; AIDS Vaccines; Alum Compounds; Female; HIV Antibodies; HIV Envelope Protein gp120; HIV Infections; HIV-1; Humans; Immunization Schedule; Male; Middle Aged; Recombinant Proteins; Substance Abuse, Intravenous; Thailand; Vaccination

2004